A UK study reveals a distinct immune “fingerprint” in the blood of patients who develop amyloid-related imaging abnormalities (ARIA) after Alzheimer's treatment with lecanemab.
Researchers from the UK College of Fine Arts and the Sanders-Brown Center on Aging investigated how complementary and supportive care programs affect life in four different Kentucky care facilities.
By applying the focus and persistence he practices at table tennis to his Alzheimer’s research, doctoral student Xizhi Xu is already making his mark at UK's College of Public Health.
Collaboration between the UK Sanders-Brown Center on Aging, Markey Cancer Center and the Department of Radiology is changing how Alzheimer’s disease and related dementias are detected, understood and treated.
UK researchers have developed a new experimental model that could point the way toward more effective Alzheimer’s disease treatments by targeting one of the brain’s most important genes for risk and resilience.
A UK team has been selected for the 2025-26 Scholars Transforming Through Research Program of the Council on Undergraduate Research. The five-month program culminates in a two-day event in Washington, D.C.
UK leadership, along with state and community leaders, joined members of the Sanders-Brown Center on Aging to celebrate 40 years of continuous funding from the NIH for their revolutionary work in the field of Alzheimer’s and dementia.
